Martin Vogelhuber

Positron Emission Tomography–Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group

Michael Fuchs, Helen Goergen, Carsten Kobe et al. · Journal of Clinical Oncology · 2019 · 229 citations

Medicine, Nuclear Medicine, Oncology +14

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial

Karolin Behringer, Helen Goergen, Felicitas Hitz et al. · The Lancet · 2014 · 181 citations

Medicine, Oncology, Pharmacology +14

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

Peter Borchmann, Annette Plütschow, Carsten Kobe et al. · The Lancet Oncology · 2021 · 168 citations

Medicine, Oncology, Radiology +13

Dyadic coping of patients with hematologic malignancies and their partners and its relation to quality of life – a longitudinal study

Jochen Ernst, Andreas Hinz, Dietger Niederwieser et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 61 citations

Nursing, Oncology, Cancer Survivorship Care +15

Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment

Claudia Ott, Michael Gerken, Daniela Hirsch et al. · Digestion · 2018 · 58 citations

Medicine, Oncology, Surgery +16